SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " founder " 1,460 found 🔀 AI-powered Shuffle
What chronic illness taught me about running a leaner, smarter business
When my health made hustle impossible, I discovered that sustainable growth comes from operational discipline, not founder endurance.
What chronic illness taught me about running a leaner, smarter business
When my health made hustle impossible, I discovered that sustainable growth comes from operational discipline, not founder endurance.
Piknik Theatre ushers in new era as health issues keep founder away
Celina Taylor will be trying to ensure that everything is in its proper place when performers take the stage at Branham Amphitheater in Strawberry Park on Sunday for Piknik Theatre‘s first performance of the 2026...
The health benefits of fermented foods
Amber Freeman, host of Bloom, joined Fermenting Fairy Founder and CEO, Lauren Mones, in the kitchen to explore the many benefits of consuming fermented foods. While fermentation may sound intimidat…
Why Perplexity's founder doesn't think the American dream is over
Aravind Srinivas, the CEO of Perplexity, praised America's startup culture on "The Joe Rogan Experience."
South Carolinians can support lifesaving global health work and demand accountability
Chad Connelly, founder of Faith Wins, writes about the lifesaving work since 2023 of a federal AIDS relief program and how he thinks Congress can save it.
Dave Portnoy reveals he is losing millions in brutal Bitcoin crash
Barstool Sports founder Dave Portnoy admits he doesn't have plans to sell Bitcoin despite its volatile nature and his struggle to predict the cryptocurrency's next move.
Founder shares AI lesson after foreign Fable access returned
A UK founder said losing access to Anthropic's Fable AI model taught him to always have a backup plan when building with AI.
Sephora Brings Beauty Leaders Together at The Business of Beauty Global Forum 2026
Founders and executives from brands including Kayali, Ilia Beauty, Summer Fridays, Merit Beauty and Danessa Myricks Beauty gathered at Stanly Ranch to discuss the partnerships shaping the industry’s future.
Entertainment-focused Cosmic Sports launches black light ice hockey venture
Cosmic Sports founder Chris Martin the success of Cosmic Baseball to the ice, announcing the launch of the glow in the dark, barnstorming property Cosmic Hockey.
How Paul Rabil is growing the business of lacrosse
Premier Lacrosse League Co-Founder Paul Rabil joins Yahoo Finance Executive Editor Brian Sozzi on Opening Bid to discuss the business of lacrosse, the sport's rising stars, and how the league plans to lower the cost of youth lacrosse.
9 Founders Who Turned Their Worst Moment Into A Business
Nine founders faced rock bottom, a death, a diagnosis, a war, a collapse, and built a business out of it. How they found strength when it felt furthest away.
GMI Cloud CEO on Business Strategy, AI Ecosystem
Alex Yeh, Founder and CEO at GMI Cloud, discusses the company's business strategy and the outlook for the AI ecosystem. He speaks with Shery Ahn from the sidelines of the IVS2026 conference in Kyoto.
The Next Chapter for Founder-Led Beauty Brands
At The Business of Beauty Global Forum 2026, Unilever Prestige CEO Mary Carmen Gasco-Buisson joined K18 founder and CEO Suveen Sahib and Tatcha founder Vicky Tsai to discuss scaling founder-led beauty brands.
Reflecting on a Year as Athlon Sports' Senior Golf Writer: Lessons from Golf's Stories
One year ago today, I officially began my run as Senior Golf Writer for Athlon Sports. By the time this opportunity arrived, I had already spent nearly three decades in golf as a PGA Professional, coach, educator, business owner, nonprofit founder and writer. The biggest lesson from my first year with Athlon Sports was not about deadlines, access or the volume of stories written.
Older workers are fighting ageism by starting their own businesses — and they’re outperforming younger entrepreneurs
A business founder at age 50 is almost twice as likely to experience success than someone in their 30s.
The engineer who became Anthropic's political secret weapon
Tom Brown, an Anthropic cofounder, helped mediate the White House complaints over Fable and Mythos. His background in AI is brief but noteworthy.
The engineer who became Anthropic's political secret weapon
Tom Brown, an Anthropic cofounder, helped mediate the White House complaints over Fable and Mythos. His background in AI is brief but noteworthy.
Victor Willis, Village People lead singer and voice behind 'Y.M.C.A.,' dies at 74
President Trump paid tribute to the Village People cofounder, who helped turn "Y.M.C.A." into one of disco's most enduring hits.
Halogen Ventures founder Jesse Draper shares her daily routine
Jesse Draper, founder of Halogen Ventures, shares her Santa Monica routine, managing investments and family while advocating for female entrepreneurs.
Wilmington Small Business Coalition: Building Momentum in 2026 by Heather McWhorter
This article was contributed by Lydia Thomas, UNCW CIE Program Manager. North Carolina continues to be one of the best states to start a business and in 2025, Wilmington, North Carolina earned a spot on the GoDaddy list of the top 10 most entrepreneurial cities in the U.S. While many know Wilmington as small beach town with exceptional food, lots of coffee shops, and fun, vibrant summer activities, a closer look reveals a thriving innovation economy. You’ll find startups emerging across industries including software, healthtech, bluetech, and fintech. At the core of this entrepreneurial ecosystem is the Wilmington Small Business Coalition, with small business advocates and entrepreneur support organizations (ESOs) dedicated to helping founders grow, thrive, and succeed. “No Wrong Door” Established in 2016, the Coalition was designed to make it easier for individuals and small businesses to access resources most suited to their particular needs. The Coalition is designed to have a “no wrong door” entryway into the regional startup ecosystem. Whether you are exploring a new idea sketched on the back of a napkin or leading a more established, growth-stage company, Coalition members can help connect you with the programs, funding opportunities, mentors, and resources best suited to your needs. No matter where you are in your entrepreneurial journey, any Coalition organization can help point you in the right direction. Coalition Members and Leadership Coalition members include the UNCW Center for Innovation and Entrepreneurship (UNCW CIE), AARP, Brunswick Community College Small Business Center, Cape Fear Community College Small Business Center, Cape Fear Region SCORE, Genesis Block Foundation, Network for Entrepreneurs in Wilmington (NEW), Small Business & Technology Development Center (SBTDC), Greater Wilmington Chamber of Commerce, YWCA Living the Dream Center for Entrepreneurship, Carolina Community Impact Fund (CCI Fund), Partner Community Capital, 717mkt Office Collaborative, NC Biotech, and Institute NC. In May 2026, the Coalition held its leadership elections, resulting in the selection of a new executive team. The following officers were elected to serve two-year terms: Chair: Lydia Thomas, UNCW CIE Vice Chair: Diane Lantz, CCI Fund Secretary: Aariene Hansley, Genesis Block Foundation Treasurer: Gloria Monroe, SBTDC Vision for the Wilmington Small Business Coalition In 2026, the Wilmington Small Business Coalition continues its work as a collaborative network of organizations. By connecting programs, expertise, and services across partner organizations, entrepreneurs can more easily find the right support at the right time. Rather than operating in silos, the Coalition aims to function as a unified, cohesive system of support for small businesses and entrepreneurs, ensuring that resources and expertise across partner organizations are visible and accessible. Through stronger collaboration and shared pathways, entrepreneurs can move more seamlessly from idea to startup to growth. Looking to dive into the Wilmington entrepreneurial ecosystem? Connect with any of the Coalition partners to get started! Connect with CIE To learn more about CIE and our services, programs, and events, join the CIE newsletter. You can also follow us on social media: Instagram, Facebook, LinkedIn, TikTok, or YouTube. CIE’s website is uncw.edu/cie. Heather McWhorter is the director of the UNCW Center for Innovation and Entrepreneurship (CIE). CIE supports innovation-forward start-ups and helps to build a vibrant innovation economy for all in southeast NC.
Dave Portnoy considers running for political office
Barstool Sports founder Dave Portnoy on Monday said he’s considering running for office, potentially against New York City Mayor Zohran Mamdani (D). Portnoy initially told Fox News’s Je…
Babson Launches Online Master’s Program in Business Creation · Babson Thought & Action
Babson’s new master’s program focuses on venture creation, as founders graduate with a master’s degree and a launch-ready business plan.
England maternity commissioner role would be ‘fundamentally dangerous’, says campaigner
Founder of Maternity Safety Alliance says recommendation in Amos report will not solve wider cultural problems
Ex-Foursquare Founder Takes On The $5 Trillion Small Business Exit Crisis
Iconic is using AI to help Main Street business owners sell smarter as $5 trillion in small business value prepares to change hands over the next decade.
Dave Portnoy discusses whether he'd run for political office
Barstool Sports founder Dave Portnoy discusses tourists coming to the U.S. for the World Cup, New York City Mayor Zohran Mamdani's policies and whether he'd ever run for political office on ‘Jesse Watters Primetime.’
How six venture capital giants are reshaping startup financing
The venture capital landscape is becoming increasingly concentrated, with six megafirms— Andreessen Horowitz, Sequoia Capital, Thrive Capital, Lightspeed Venture Partners, Founders Fund and General Catalyst—now raising more capital than all other U.S. venture firms combined over the past two years, Inc. reports. Their growth has been fueled by the enormous capital requirements of AI startups, […]
How The Nitro Bar became a booming coffee business
As part of the series Women Mean Business, NBC News' Savannah Sellers spoke with The Nitro Bar co-founder Audrey Finocchiaro about building a fast-growing coffee brand, expanding to New York City, and turning a bold idea into a thriving business.
Why a creator economy startup founder pivoted to data centers
Leonhard Soenke founded a creator economy startup. Now he splits his time between San Francisco and Texas working in data centers. Here's why.
Flexjet buys Steve Varsano’s The Jet Business | Corporate Jet Investor
TikTok’s favourite business jet broker has been bought by Flexjet. Steve Varsano, founder of The Jet Business will become president.
New look, same sole: Charm City Run founder keeps Baltimore moving
In Good Company: Josh Levinson made Charm City Run specifically for Baltimore. For nearly 25 years, the region has loved the business back.
John West: Science and the American Founding
“Today, many people think that belief in a Creator is a subjective preference based on their personal faith. But that was not the view of America’s Founders.”
Ex-Google engineer says Larry Page, Sergey Brin and Sundar Pichai share the same trait—it’s the lesson he swears by as a $7.2 billion AI CEO
$7.2 billion AI founder Arvind Jain ‘observed’ Sundar Pichai at Google for years before he became CEO—he learned you need to ‘think crazy’ to be successful
Ex-Google engineer says Larry Page, Sergey Brin and Sundar Pichai share the same trait—it’s the lesson he swears by as a $7.2 billion AI CEO
$7.2 billion AI founder Arvind Jain ‘observed’ Sundar Pichai at Google for years before he became CEO—and learned you need to ‘think crazy’ to be successful
Spotlight falls on Ocado boss Tim Steiner’s £100m in payouts
Reports claim replacement being lined up for co-founder amid concern over high pay and company’s struggling share price
How Domo went from a $2.8 billion darling to fighting for its survival
Domo has been rocked by executive departures, new competition from AI agents, and the drunken-driving arrest of its founder and CEO, Josh James.
The fittest founder in the room got cancer. Here's how he used AI to fight back.
When confronted with cancer, Connor Christou fed everything tied tied to his regime — blood results, scan data, wearable output, journal entries — into Claude.
Recent rulings show that SCOTUS has ditched reason for politics
'The flurry of 6-3 decisions shows how SCOTUS has become a political body, not the judicial one the founders of our Constitution sorely aspired to,' writes an L.A. Times reader.
Perplexity, Kalshi, Replit insiders share how to get a startup job
We asked startup founders, recruiters, and hiring managers what to do — and not to do — to boost your chances of getting an offer.
'Godfather of SaaS' says you can't get truly rich working from home
SaaStr founder Jason Lemkin agrees with Flexport CEO Ryan Peterson's skepticism of remote work.
A day in the life of Nicky Hilton between London and New York
Nicky Hilton, socialite and cofounder of custom jewelry brand theo grace, splits her time between London and NYC. Here's a day in her life.
Are You Falling Into These 5 AI Traps? Here's How Smart Leaders Avoid Them.
Artificial intelligence is making founders fall into the same leadership traps. Here's how to make sure you avoid them.
Xprize founder says 'humans behave better when they’re being watched'
Peter Diamandis is the latest tech executive to argue that global surveillance will make the world a better place, following Larry Ellison's comments in 2024.
How Outward Intelligence founders bootstrapped to seven-figure revenue
Three friends with résumés spanning Google, Palantir, and Harris Poll skipped venture capital and bootstrapped their startup instead.
Cabo Verde Is a Breakout Star of the World Cup. So Is the Family-Owned Business That Designed Its Jerseys
After more than three decades manufacturing apparel, Capelli Sport co-founder and CEO George Altirs found his company’s biggest billboard yet—3,500 miles away from his midtown Manhattan office.
Priscilla Chan on science, disease prevention and the future of medicine
CNBC's Becky Quick sits down for a conversation with Dr. Priscilla Chan, co-founder of Biohub, at Aspen Ideas: Health.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Poppi founder speaks about building a billion-dollar soda business
Allison Ellsworth, the founder of the viral soda brand Poppi, sits down with NBC News' Savannah Sellers to discuss how she turned a personal health issue into a billion-dollar cultural phenomenon.
New polls show Americans’ complicated feelings about the country, 250 years on
More than three-quarters of Americans think the country’s founders would be disappointed with the US today, according to a Gallup poll released this week – one of several new surveys spotlighting the public’s complicated feelings about the nation’s legacy as it approaches its 250th anniversary.
Louisville doctor, nurse and nonprofit founder charged in federal health care fraud crackdown
Federal prosecutors in the Western District of Kentucky announced charges in four separate cases involving alleged schemes to defraud Medicare and Medicaid, misuse medical credentials and controlled substances, and submit
South Korea arrests Shincheonji church leader for meddling in politics, media report
A South Korean court ordered the arrest of Lee Man-hee, the founder of the Shincheonji Church of Jesus, over allegations he orchestrated an illegal scheme for followers to join a political party, news reports said.
The biotech founder asking why good science gets stuck
As an undergraduate, Alinta Furnell led student societies, pitched startup ideas and built biotechnology ventures. Now, the UNSW alumna is investigating one of innovation’s biggest challenges – why so many scientific breakthroughs never make it beyond the lab.
Creators are rethinking the exit
Founders like Clea Shearer, Hoda Kotb and Mel Robbins are prioritizing control.
Hollister’s First-Ever Target Collection Reveals a 3-Step Growth Strategy Any Business Can Copy
Hollister's first home collection is a move from closet share to lifestyle share, and a growth playbook any founder can borrow.
How wearable tech aims to innovate women's health care
Clair Health co-founder and CTO (Chief Technology Officer) Abhinav Agarwal comes on Asking for a Trend to explain how the company is using AI models in its hormone monitoring device and how new doctors, specifically OBGYNs, can use it to learn more.
Ryan Serhant’s Advice for Building a Business That Lasts
Ahead of his appearance at NAR NXT, the SERHANT. founder and CEO shares lessons on discipline, branding and playing the long game in real estate.
Alo Yoga Primed for IPO After Sale of Its T-Shirt Business
The sale of Bella+Canvas, which has not closed yet, would give founders Danny Harris and Marco DeGeorge more flexibility and options for the Lululemon challenger.
Foley Entertainment Group Announces VGK Founder Bill Foley’s Bid to Bring NBA Franchise to Las Vegas
Foley Entertainment Group Announces VGK Founder Bill Foley’s Bid to Bring NBA Franchise to Las Vegas...
It Ain’t Just Sports: CPR, tennis & a second chance with Adrian Murray
In this episode: We sit down with Adrian Murray, co-founder of T.R.I.N.I.T.Y Tennis, to talk about purpose, perseverance, and using tennis to promote heart health and life-saving skills.
I'm a billionaire founder and father of 5. I parent them differently.
Zynga founder Mark Pincus says giving children agency, responsibility, and room for eccentricity matters more than achievement.
MOSH Co-Founded by Maria Shriver and Patrick Schwarzenegger
Go Behind the Brand with Maria Shriver, co-founder of MOSH.
Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
Nine months after announcing its seed funding round, Prosper AI banked $30 million to scale its agentic AI platform to power administrative tasks from patient scheduling to insurance verification a | Prosper AI banked $30 million to scale its agentic AI platform to power administrative tasks from patient scheduling to insurance verification and patient billing.
‘Founder’ Is the New Brass Ring for Computer Science Grads
The share of employed 2025 CS graduates with the title doubled in a study of 20 universities with renowned tech programs.
From Field to Frock: Madison festival promotes Midwest linen
Midwest Linen Revival founder Leslie Schroeder wants to revive flax-to-linen production in the region. The Field to Frock festival returns June 23–28.
Ubisoft co-founder Claude Guillemot has died in a plane crash
The French businessman was 69 years old
Ubisoft co-founder Claude Guillemot dies in plane crash
Guillemot was one of two people killed in the accident on 19th June in Brittany, France, after the twin-engine plane – registered to Guillemot – crashed.
Ubisoft co-founder Claude Guillemot dies in plane crash
Claude Guillemot, who founded Ubisoft with his four brothers, has died at the age of 69.
Ken Griffin fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Billionaire fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Billionaire fires back at Mamdani, says business leaders must 'fight for their city'
Citadel founder Ken Griffin urges New York business leaders to speak up against Mayor Zohran Mamdani's tax proposals, warning the city risks losing talent.
Owner, founder of St. Louis business Jilly’s Cupcake Bar & Cafe dies
Jilly’s Cupcake Bar & Cafe shared Saturday that the business’ owner and founder, Jill Segal, has died.
Claude Guillemot, Ubisoft Co-Founder, Is Dead After Plane Crash in France
Claude Guillemot, 69, founded the video game company, which was also known for the hit Far Cry, with his brothers in 1986. He was killed in western France.
Ubisoft co-founder Claude Guillemot killed in plane crash that claimed 2 lives: report
Claude Guillemot, one of the five brothers who founded Ubisoft in 1986, reportedly died in a twin-engine plane crash in La Baule, France.
Ubisoft co-founder Claude Guillemot killed in plane crash that claimed 2 lives: report
Claude Guillemot, one of the five brothers who founded Ubisoft in 1986, reportedly died in a twin-engine plane crash in La Baule, France.
Co-founder of ‘Assassin’s Creed’ video game giant dies in plane crash
Ubisoft co-founder Claude Guillemot, 69, died in the crash on France’s Atlantic coast along with another occupant of a twin-engine Cessna 421.
Claude Guillemot, co-founder of 'Assassin's Creed' maker Ubisoft, killed in plane crash in France
A founder of Ubisoft, the global gaming company behind Assassin's Creed, has been killed in a plane crash in western France.
Claude Guillemot, co-founder of video game maker Ubisoft, dies in plane crash
Claude Guillemot and a flight instructor were flying in a twin-motor Cessna 421 on Friday evening. An investigation into the crash is underway.
Ubisoft cofounder Claude Guillemot dies in plane crash
Claude Guillemot died after a Cessna plane carrying the Ubisoft founder crashed on Friday in western France. He was 69.
Ubisoft Co-Founder Claude Guillemot Dies In Plane Crash
Ubisoft Co-Founder Claude Guillemot Dies In Plane Crash
Ubisoft's co-founder Claude Guillemot dies in plane crash
Claude Guillemot, who co-founded French video-game publisher Ubisoft with his brothers in 1986, has died, the company said on Saturday.
Assassin’s Creed co-creator killed in plane crash in France
Claude Guillemot, a founder of Assassin's Creed maker Ubisoft, has died in a plane crash in western France.
Founder of Assassin's Creed maker Ubisoft killed in a plane crash in western France
Claude Guillemot, a founder of Assassin's Creed maker Ubisoft, has died in a plane crash in western France
Ubisoft Co-Founder Claude Guillemot Dies in Air Crash at Age 69
Claude Guillemot, who co-founded French video-game publisher Ubisoft Entertainment SA with his brothers in 1986, has died, according to the company. He was 69.
Replika founder warns of 'crazy protests' over AI's jobs impact
Eugenia Kuyda, the founder of the AI chatbot startup Replika, says fears about AI eliminating jobs are justified — and will lead to backlash.
Ubisoft Co-Founder Dies in Tragic Plane Crash
69-year-old Ubisoft co-founder Claude Guillemot died in a passenger plane crash on June 19.
A day in the life of GORUCK cofounder Emily McCarthy
Emily McCarthy, who founded GORUCK with her husband Jason McCarthy, spends her days biking with her kids to their school and taking rucking meetings.
Frive meals founder: ‘My business saved my life’
Having nothing to wake up for led George Taylor down a self-destructive path. His microwave meal business gave him a purpose
Border Report Live: New World screwworm adding to overburdened, under-funded US health system
Although the chance of New World screwworm infecting humans is extremely rare, Dr. Tyler Evans, CEO and co-founder of the Wellness and Equity Alliance tells Border Report Live that the threat is ad…
Blueprint Capital Advisors CEO Jacob Walthour Featured on The New Jersey Business Media Podcast Discusses Access, Capital, and Opportunity for Entrepreneurs
/PRNewswire/ -- Jacob Walthour, founder and CEO of Blueprint Capital Advisors and creator of the Power 100 initiative, appears as a featured guest on The New...
‘The purpose of the rule is fascism’: scientists fight back against planned Trump research cuts
Stand Up for Science founder says proposal to control how grants are spent would ‘dismantle US science ecosystem’
Savage Entertainment Announces June 26 AWAL/Sony Music Release Featuring PO1300, Albee Al and WayG
Camden, NJ, June 18, 2026 (GLOBE NEWSWIRE) -- Savage Entertainment announced today that its founder and recording artist PO1300 will release a ...
Savage Entertainment Announces June 26 AWAL/Sony Music Release Featuring PO1300, Albee Al and WayG
Savage Entertainment founder and rising New Jersey artist prepares for the June 26 release of his latest single, bringing together one of the state's most respected voices and the next generation of Camden talent.Camden, NJ, June 18, 2026 (GLOBE NEWSWIRE) -- Savage Entertainment announced today that its founder and recording artist PO1300 will release a new single on June 26 featuring New Jersey artist Albee Al and fellow Savage Entertainment artist WayG. The upcoming release marks a significant
Tech entrepreneur Dug Song helps Michigan's future business founders
After selling a cybersecurity company for billions, the son of a Korean immigrant has focused on making it easier for those who follow.
Mydays founder expresses interest in ProSiebenSat.1's adventure business
The founder of adventure experience business Mydays, now part of broadcaster ProSiebenSat.1, told Reuters he and co-investors are looking into buying back the unit, potentially pitting them against German entrepreneur Jochen Schweizer.
The Carry-On Essentials Female Founders Pack For Business Travel
The best carry-on essentials for business travel take you from a flight to the boardroom with ease. We spoke with top female executives to get their favorite picks.
Gabe Newell, founder of Bellevue’s Valve, buys $70.8M Florida mansion
The 20,000-square-foot house spans from the ocean to the Intracoastal Waterway, with a private dock and a tunnel leading directly from the house to the ocean shore.
Alzheimer's Drug Discovery Foundation Begins Search for New Chief Science Officer as Co-Founder Dr. Howard Fillit Transitions to Emeritus Role
/PRNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) today announced that its Co-Founder and Chief Science Officer (CSO), Dr. Howard Fillit, is...
Sports is driving a large part of the entertainment economy, says Activate CEO Michael Wolf
Michael Wolf, Activate Consulting CEO and co-founder, joins 'Squawk Box' to discuss Versant's media rights agreement with the WNBA, appetite for live sports, Fox's $22B acquisition of Roku, Paramount-WBD merger, and more.
Sports is driving a large part of the entertainment economy, says Activate CEO Michael Wolf
Michael Wolf, Activate Consulting CEO and co-founder, joins 'Squawk Box' to discuss Versant's media rights agreement with the WNBA, appetite for live sports, Fox's $22B acquisition of Roku, Paramount-WBD merger, and more.